So, What About the Yellow Stuff: Plasma

The presentation discusses the current the state of the science regarding plasma transfusions as it relates to blood health.

Lecture Presenter
Image
Carolyn Burns, MD
Carolyn Burns, MD
CMO and Co-Founder, Collaborative Clinical Consulting, LLC
Immediate Past President, Society for the Advancement of Patient Blood Management (SABM)

Carolyn Burns, MD, is a board-certified pathologist (AP/CP) and served as the medical director/chief of Pathology of the Jewish Hospital Healthcare System, Department of Pathology in Louisville, Kentucky, from 1991-2011. This included medical directorship of Surgical Pathology, Clinical Laboratory, and the Transfusion/Tissue Services for this five-hospital system. She has previously been an assistant clinical professor in the Department of Pathology at the University of Louisville and on the advisory board and a guest lecturer for the Bellarmine University Clinical Laboratory Science Program.

After earning her microbiology undergraduate degree and her subsequent medical degree, Dr. Burns completed an internship in general surgery followed by a pathology residency at the University of Louisville. Dr. Burns is the current immediate past president for the Society for the Advancement of Patient Blood Management.

Dr. Burns is an active member of several medical societies, including AABB and IARS. She has numerous publications in peer-reviewed journals and textbooks and is often sought after as an engaging speaker, both nationally and internationally, regarding patient blood management (PBM) and transfusion practices.

Dr. Burns is a PBM physician advisor/consultant working with numerous hospitals and systems throughout the U.S. She is the CMO and co-founder of Collaborative Clinical Consulting, LLC, a company providing PBM education, implementation services, and perioperative assessment.

Objectives

After this presentation, participants will be able to:

Review the risks of transfusion, the pillars of PBM, and introduce the concept of blood health
Discuss the current state of science regarding plasma, in general, in specific clinical patient subsets, and associated outcomes
Review the most recent guidelines from the Society for Interventional Radiology regarding prophylactic transfusion of plasma